Prelude Capital Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$17.76 - $21.24 $34,596 - $41,375	-1,948 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$17.99 - $22.22 $4,335 - $5,355	-241 Reduced 11.01%	1,948 $37,000
Q2 2020 Aug 14, 2020	BUY	$14.25 - $22.46 $31,193 - $49,164	2,189 New	2,189 $49,000
Q4 2019 Feb 14, 2020	SELL	$17.07 - $20.64 $41,565 - $50,258	-2,435 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$19.12 - $22.62 $66,920 - $79,170	-3,500 Reduced 58.97%	2,435 $48,000
Q2 2019 Aug 14, 2019	SELL	$18.92 - $22.96 $56,760 - $68,880	-3,000 Reduced 33.58%	5,935 $125,000
Q1 2019 May 15, 2019	BUY	$19.46 - $25.28 $104,850 - $136,208	5,388 Added 151.9%	8,935 $183,000
Q4 2018 Feb 14, 2019	BUY	$17.72 - $22.51 $62,852 - $79,842	3,547 New	3,547 $71,000
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.6 $25,602 - $34,300	-1,750 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.23 - $20.35 $30,152 - $35,612	1,750 New	1,750 $33,000

282

35.2M

25.5K

24.8K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.26B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.